跳转至内容
Merck
CN
  • Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis.

Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis.

The Journal of biological chemistry (2004-10-09)
Thelma Thompson, Christian Tovar, Hong Yang, Daisy Carvajal, Binh T Vu, Qunli Xu, Geoffrey M Wahl, David C Heimbrook, Lyubomir T Vassilev
摘要

The p53 tumor suppressor is a key mediator of the cellular response to stress. Phosphorylation induced by multiple stress-activated kinases has been proposed to be essential for p53 stabilization, interaction with transcriptional co-activators, and activation of p53 target genes. However, genetic studies suggest that stress-activated phosphorylation may not be essential for p53 activation. We therefore investigated the role of p53 phosphorylation on six key serine residues (Ser(6), Ser(15), Ser(20), Ser(37), Ser(46), and Ser(392)) for p53 activation using nutlin-3, a recently developed small molecule MDM2 antagonist. We show here that nutlin does not induce the phosphorylation of p53. Comparison of the activity of unphosphorylated and phosphorylated p53 induced by the genotoxic drugs doxorubicin and etoposide in HCT116 and RKO cells revealed no difference in their sequence-specific DNA binding and ability to transactivate p53 target genes and to induce p53-dependent apoptosis. We conclude that p53 phosphorylation on six major serine sites is not required for activation of p53 target genes or biological responses in vivo.

材料
货号
品牌
产品描述

Sigma-Aldrich
Anti-p21WAF1 (Ab-1) Mouse mAb (EA10), liquid, clone EA10, Calbiochem®
Sigma-Aldrich
MDM2 Antagonist, Nutlin-3, Racemic, The MDM2 Antagonist, Nutlin-3, Racemic, also referenced under CAS 548472-68-0, controls the biological activity of MDM2. This small molecule/inhibitor is primarily used for Cancer applications.
Sigma-Aldrich
MDM2 Antagonist IV, Nutlin-3a, The MDM2 Antagonist IV, Nutlin-3a, also referenced under CAS 675576-98-4, controls the biological activity of MDM2. This small molecule/inhibitor is primarily used for Cancer applications.